Advanced Search

Press Release For The Medicinal Product For Human Use "zonegran»

Original Language Title: Comunicato relativo al medicinale per uso umano «Zonegran»

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
Specialty: ZONEGRAN.
Please be advised that the scientific technical Committee at its meeting on 10 December 12, 2014, 11 and has delivered a negative opinion to the listings there ' for the new indication below: adjunctive therapy in the treatment of partial seizures with or without secondary generalization, adolescents and children from 6 years of age.